FRIDAY, Dec. 29, 2023 (HealthDay News) — More patients could benefit from immunotherapy, a highly effective treatment for some cancers, new research suggests. Revising current testing guidelines so that a more sophisticated test could be used more often would enable 6,000 more people in the United States to receive theContinue Reading
WEDNESDAY, Dec. 27, 2023 (HealthDay News) — Getting your preventive screening colonoscopy could be even more of a lifesaver than you thought, a new analysis finds. The two gold standard tests for spotting cancers and polyps of the colon — colonoscopy and sigmoidoscopy — offer double the benefit determined inContinue Reading
THURSDAY, Dec. 21, 2023 (HealthDay News) — Kids who’ve survived cancer face many health challenges, and a heightened risk for diabetes is one of them, new research shows. A team at St. Jude’s Children’s Hospital in Memphis, Tenn., reports that these children have twice the odds of developing prediabetes (aContinue Reading
WEDNESDAY, Dec. 20, 2023 (HealthDay News) — Long left to the fringes of the recreational drug culture, psilocybin — the hallucinatory ingredient in “magic mushrooms” — has recently been making inroads as a legitimate (and fast-acting) antidepressant. Research published Dec. 18 in Cancer shows its benefits may extend to peopleContinue Reading
WEDNESDAY, Dec. 20, 2023 (HealthDay News) — Many patients with advanced colon cancers who are successfully treated with immunotherapy and then stop those treatments appear to face little risk of tumor progression two years later. That’s the main finding from a study that tracked outcomes for 64 people treated forContinue Reading
TUESDAY, Dec. 19, 2023 (HealthDay News) — At-home tests for colon cancer make this important screening readily available to folks who can’t afford or would rather not go through a colonoscopy. Unfortunately, more than 1 in 10 at-home tests sent to a lab are unusable, mainly due to mistakes madeContinue Reading
FRIDAY, Dec. 15, 2023 (HealthDay News) — A new melanoma vaccine has shown its mettle in battling the deadly skin cancer in a new trial. People with advanced melanomas who received the vaccine plus Merck’s cancer drug Keytruda were 49% less likely to die or have their cancer return afterContinue Reading
FRIDAY, Dec. 8, 2023 (HealthDay News) — Some women with a very early form of breast cancer known as ductal carcinoma in situ (DCIS) can safely skip follow-up radiation therapy after surgery, new research suggests. Results from a sophisticated genetic test are key to the decision to either undergo orContinue Reading
FRIDAY, Dec. 8, 2023 (HealthDay News) — Sydnee Meth survived breast cancer, but she wasn’t prepared for the aftereffects of her treatment. Doctors removed the lymph nodes from Meth’s right armpit during her second bout with breast cancer in 2014, and as a result she developed a painful condition calledContinue Reading
FRIDAY, Dec. 8, 2023 (HealthDay News) — Could blockbuster diabetes and weight-loss meds such as Ozempic, Wegovy, Mounjaro and Zepbound also lower users’ odds for colon cancer? New research suggests they might. All of these medications (and more) fall into a class of diabetes drugs known as glucagon-like peptide-1 receptorContinue Reading